- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01988623
Pivotal Response Treatment for Individuals With Intellectual Disabilities
January 9, 2021 updated by: Antonio Hardan, Stanford University
The investigators will assess the efficacy of Pivotal Response Treatment (PRT) in the treatment of communication deficits in children with intellectual disabilities.
By collecting information about parent and child functioning before and after PRT, The investigators will be able to determine whether the intervention is effective in improving child communication and reducing parent stress.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Stanford, California, United States, 94305-5719
- Stanford University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 13 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria for Individuals with Intellectual Disabilities:
- Participants will have an age range between 2 and 17.11 years of age inclusive
- Male or female
- Diagnosis of an intellectual disability based on the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10), and an expert clinical evaluation
- have historical evidence of significant abnormal developmental milestones as determined by neurological history
- care provider that will reliably bring subject to study visits, and is trustworthy to provide accurate accounts of services provided to the subject
Inclusion Criteria for Individuals with Speech Delay/Language Disorder:
- Participants will have an age range between 2 and 17.11 years of age inclusive
- Male or female
- Diagnosis of a speech delay based on the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10), and an expert clinical evaluation
- Preschool Language scale (PLS) score of at least 1 standard deviations below age level (for children in the age range of 2-6.11)
- care provider that will reliably bring subject to study visits, and is trustworthy to provide accurate accounts of services provided to the subject
Exclusion Criteria:
- medically unstable (such as having unstable seizures)
- primary diagnosis of Autism Spectrum Disorder (ASD) is exclusionary as determined by the investigators
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pivotal Response Treatment (PRT)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from Baseline on the MacArthur-Bates Communication Development Inventory at 6, 12, and 24 weeks
Time Frame: 6, 12 and 24 weeks
|
6, 12 and 24 weeks
|
|
Change from Baseline in communication during parent-child and clinician-child interactions at 6, 12, and 24 weeks
Time Frame: 6, 12 and 24 weeks
|
6, 12 and 24 weeks
|
|
Change from Baseline on the Social Responsiveness Scale (SRS) at 6, 12, and 24 weeks
Time Frame: 6, 12 and 24 weeks
|
6, 12 and 24 weeks
|
|
Change from Baseline on the Clinical Global Impression Scale at 6, 12, and 24 weeks
Time Frame: 6, 12, and 24 weeks
|
6, 12, and 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change from Baseline on the Vineland Adaptive Behavior Scales, Second Edition (VABS-II) at 6, 12, and 24 weeks
Time Frame: 6, 12 and 24 weeks
|
6, 12 and 24 weeks
|
|
Change from Baseline on the Parenting Stress Index (PSI) at 6, 12, and 24 weeks
Time Frame: 6, 12, and 24 weeks
|
6, 12, and 24 weeks
|
|
Change from Baseline on the Family Empowerment Scale (FES) at 6, 12, and 24 weeks
Time Frame: 6, 12, and 24 weeks
|
6, 12, and 24 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Antonio Y. Hardan, M.D., Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 11, 2012
Primary Completion (Actual)
September 30, 2017
Study Completion (Actual)
September 30, 2017
Study Registration Dates
First Submitted
November 13, 2013
First Submitted That Met QC Criteria
November 19, 2013
First Posted (Estimate)
November 20, 2013
Study Record Updates
Last Update Posted (Actual)
January 12, 2021
Last Update Submitted That Met QC Criteria
January 9, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-25229
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.